Curcumin, A Multi-Functional Chemopreventive Agent, Blocks Growth of Colon Cancer Cells by Targeting β-Catenin-Mediated Transactivation and Cell–Cell Adhesion Pathways (original) (raw)
References
Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of cur-cumin: Preclinical and clinical studies. Anticancer Res23: 363–398. Google Scholar
Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H(1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Nat Cancer Inst89: 1881–1886. Google Scholar
Barker N, Morin PJ, Clevers H (2000) The Yin-Yang of TCF/β-catenin signalling. Adv Cancer Res77: 1–24. Google Scholar
Ben-Ze'ev A, Geiger B (1998) Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signalling and cancer. Curr Opin Cell Biol10: 629–639. Google Scholar
Bodmer BF (1996) The somatic evolution of cancer. The Harveian Oration of 1996. J Roy Coll Phys Lond31: 82–89. Google Scholar
Bordonaro M, Mariadason JM, Aslam F, Heerdt BG, Augenlicht LH (1999) Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and thrichostatin A but not curcumin. Cell Growth Differ10: 713–720. Google Scholar
Boxer LM, Dang CV (2001) Translocations involving c-myc and c-myc function. Oncogene20: 5595–5610. Google Scholar
Brancolini C, Sgorbissa A, Schneider C (1998) Proteolytic processing of the adherens junctions components beta-catenin and gamma-catenin/ plakoglobin during apoptosis. Cell Death Differ5: 1042–1050. Google Scholar
Breen E, Steel G, Mercurio AM (1995) Role of the E-cadherin– catenin complex in modulating cell–cell and cell–matrix adhesive properties of invasive colon carcinoma cells. Ann Surg Oncol2: 378–385. Google Scholar
Browne SJ, Williams AC, Hague A, Butt AJ, Paraskeva C (1994) Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int J Cancer59: 56–64. Google Scholar
Browne SJ, MacFarlane M, Cohen GM, Paraskeva C (1998) The adenomatous polyposis coli protein and retinoblastoma protein are cleaved early in apoptosis and are potential substrates for caspases. Cell Death Differ5: 206–213. Google Scholar
Bush JA, Cheung KJ, Li G (2001) Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res271: 305–314. Google Scholar
Chainani-Wu N (2003) Safety and anti-inflammatory activity of curcumin: A component of turmeric (Curcuma longa). J Altern Complement Med9: 161–168. Google Scholar
Chapkin RS, Fan Y, Lupton JR (2000) Effect of diet on colonic-programmed cell death: Molecular mechanism of action. Toxicol Lett112–113: 411–414. Google Scholar
Chen HW, Huang HC (1998) Effects of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol124: 1029–1040. Google Scholar
Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J, Wang C (2001) Wnt-1 signalling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol152: 87–96. Google Scholar
Chen YR, Tan TH(1998) Inhibition of the c-Jun N-terminal kinase (JNK) signalling pathway by curcumin. Oncogene17: 173–178. Google Scholar
Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res21(4B), 2895–2900. Google Scholar
Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S (1998) Chemo-preventive agent resveratrol, a natural product derived from grapes, triggers CD95 signalling-dependent apoptosis in human tumour cells. Blood92: 996–1002. Google Scholar
Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Human Mol Genet10: 721–733. Google Scholar
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumourigenesis. Cell61: 759–767. Google Scholar
Fukuda K (1999) Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells. Int J Biochem Cell Biol31: 516–529. Google Scholar
Gattardi CJ, Gumbiner BM (2001) How β-catenin interacts with its partners. Curr Biol11: R792–R794. Google Scholar
Goel A, Boland CR, Chauhan DP (2001) Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett172: 111–118. Google Scholar
Goss KH, Groden J (2000) Biology of the adenomatous polyposis coli tumour suppressor. J Clin Oncol18: 1967–1979. Google Scholar
Green DW, Roh H, Pippin JA, Drebin JA (2001) Beta-catenin antisense treatment decreases beta-catenin expression and tumour growth rate in colon carcinoma xenografts. J Surg Res101: 16–20. Google Scholar
Gumbiner BM (2000) Regulation of cadherin adhesive activity. J Cell Biol148: 399–404. Google Scholar
Hajra KM, Fearon ER (2002) Cadherin and catenin alterations in human cancer. Genes Chrom Cancer34: 255–268. Google Scholar
Hao X, Frayling IM, Willcocks TC, Han W, Tomlinson IP, Pignatelli MN, Pretlow TP, Talbot IC (2002) Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis. Virchows Arch440: 362–366. Google Scholar
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science281: 1509–1512. Google Scholar
Hirohashi S, Kanai Y (2003) Cell adhesion system and human cancer morphogenesis. Cancer Sci94: 575–581. Google Scholar
Huelsken J, Birchmeier W (2001) New aspects of Wnt signalling pathways in higher vertebrates. Curr Opin Genet Dev11: 547–553. Google Scholar
Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, Bodmer WF (1997) Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA94: 10330–10334. Google Scholar
Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y, Yabu Y (1994) Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem Biophys Res Commun204: 898–904. Google Scholar
Jaiswal AS, Marlow BP, Gupta N, Narayan S (2002) β-Catenin-mediated transactivation and cell–cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene21: 8414–8427. Google Scholar
Jee SH, Shen SC, Tseng CR, Chiu HC, Kuo ML(1998) Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol111: 656–661. Google Scholar
Jiang MC, Yang-Yen HF, Yen JJ, Lin JK (1996) Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer26: 111–120. Google Scholar
Kakar SS, Roy D (1994) Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett87: 85–89. Google Scholar
Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS (1999) Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res59: 597–601. Google Scholar
Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC (1994) Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials. Cancer Res54(Suppl.) 2015s–2024s. Google Scholar
Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, Hong WK, Parkinson DR, Bagheri D, Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swallm LM, Sigman CC (1996) Strategy and planning for chemopreventive drug development: Clinical development plans II. J Cell Biochem26(Suppl.): 54–71. Google Scholar
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H (1997) Constitutive transcriptional activation by a beta-catenin–Tcf complex in APC-/- colon carcinoma. Science275: 1784–1787. Google Scholar
Korutla L, Cheung JY, Mendelsohn J, Kumar R (1995) Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis16: 1741–1745. Google Scholar
Kuttan R, Sudheeran PC, Josph CD (1987) Turmeric and curcumin as topical agents in cancer therapy. Tumori73: 29–31. Google Scholar
Law BK, Waltner-Law ME, Entingh AJ, Chytil A, Aakre ME, Norgaard P, Moses HL (2000) Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen. J Biol Chem275: 38261–38267. Google Scholar
Limtrakul P, Anuchapreeda S, Lipigoson S, Dunn FW (2001) Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin. BMC Cancer1: 1–7. Google Scholar
Ling Y, Zhong Y, Perez-Soler R (2001) Disruption of cell adhesion and caspase-mediated proteolysis of beta-and gamma-catenins and APC protein in paclitaxel-induced apoptosis. Mol Pharmacol59: 593–603. Google Scholar
Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, Martucci C, Newmark HL, Bertagnolli MM (2000) Plant phenolics decrease intestinal tumours in an animal model of familial adenomatous polyposis. Carcinogenesis21: 921–927. Google Scholar
Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ, Hanski C (1999) Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signalling in human colorectal carcinomas. Proc Natl Acad Sci USA96: 1603–1608. Google Scholar
Manson MM, Gescher A, Hudson EA, Plummer SM, Squires MS, Prigent SA (2000) Blocking and suppressing mechanisms of chemo-prevention by dietary constituents. Toxicol Lett112–113: 499–505. Google Scholar
McCarty MF(2001) Current prospects for controlling cancer growth with non-cytotoxic agents–nutrients, phytochemicals, herbal extracts, and available drugs. Med Hypoth56: 137–154. Google Scholar
Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB, Fini ME (2000) Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem275: 10405–10412. Google Scholar
Moragoda L, Jaczewski R, Majumdar AP(2001) Curcumin induced mod-ulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res21(2a): 873–878. Google Scholar
Muller T, Choidas A, Reichman E, Ullrich A (1999) Phosphorylation and free pool of b-catenin are regulated by tyrosine kinases and tyro-sine phosphatases during epithelial cell migration. J Biol Chem274: 10173–10183. Google Scholar
Muto T, Bussey HJ, Morson BC (1995) The evolution of cancer of the colon and rectum. Cancer36: 2251–2270. Google Scholar
Papkoff J (1997) Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and v-Src. J Biol Chem272: 4536–4543. Google Scholar
Paulsen JE (2000) Modulation by dietary factors in murine FAP models. Toxicol Lett112–113: 403–409. Google Scholar
Pelengaris S, Khan M, Evan G (2002) C-Myc: More than just a matter of life and death. Nat Rev Cancer2: 764–776. Google Scholar
Phan TT, See P, Lee ST, Chan SY (2001) Protective effects of curcumin against oxidative damage on skin cells _in vitr_o: Its implication for wound healing. J Trauma51: 927–931. Google Scholar
Polakis P (2000) Wnt signalling and cancer. Genes Dev14: 1837–1851. Google Scholar
Rao CV, Rivenson A, Simi B, Reddy BS (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound in mice. Cancer Res55: 259–266. Google Scholar
Roh H, Green DW, Boswell CB, Pippin JA, Drebin JA(2001) Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res61: 6563–6568. Google Scholar
Schmeiser K, Grand RJ (1999) The fate of E-and P-cadherin during the early stages of apoptosis. Cell Death Differ6: 377–386. Google Scholar
Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP (2001) Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res7: 1894–1900. Google Scholar
Singh S, Aggarwal BB (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem270: 24995–25000. Google Scholar
Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, Oshima M, Taketo MM (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(716) knockout mice. Nat Med7: 1048–1051. Google Scholar
Srimal RC, Dhawan BN (1973) Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol25: 447–452. Google Scholar
Steinhusen U, Badock V, Bauer A, Behrens J, Wittman-Liebold B, Dorken B, Bommert K (2000) Apoptosis-induced cleavage of beta-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J Biol Chem275: 16345–16353. Google Scholar
Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O (2001) Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem276: 4972–4980. Google Scholar
Steinmetz KA, Potter JD (1991) Vegetables, fruit, and cancer. I. Epidemiology. Cancer Cause Control2: 325–357. Google Scholar
Wadham C, Gamble JR, Vadas MA, Khew-Goodall Y (2003) The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin. Mol Biol Cell14: 2520–2529. Google Scholar
Williams C, Shattuck-Brandt RL, DuBois RN (1999) The role of COX-2 in intestinal cancer. Ann NY Acad Sci889: 72–83. Google Scholar
Wu Y, Chen Y, Xu J, Lu L (2002) Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Za Zhi24: 348–352. Google Scholar
Yap AS, Brieher WM, Gumbiner BM (1997) Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol13: 119–146. Google Scholar